2012 ACR/ARHP Annual Meeting

November 9-14, 2012. Washington, DC.

View by Title View Sessions

Jump to: View All • a [b] c d e f g h i j k l m n o p q r s t u v w x y z

Abstract Number: 1757

B Cell Activating Factor Receptor Expression After Rituximab: Comparison of Patients with Rheumatoid Arthritis and Thrombotic Thrombocytopenic Purpura
Abstract Number: 1764

B Cells in Early Rheumatoid Arthritis: ZAP-70 More Than SYK Characterize Seropositive Disease
Abstract Number: 610

B Lymphocyte Stimulator Levels Are Higher in Caucasian SLE Patients Earlier in Disease Course and Predict Damage Accumulation
Abstract Number: 482

B-Lymphocyte Count Is Not Associated with an Increased Risk of Infection in Patients Treated with Rituximab for Auto-Immune Diseases
Abstract Number: 618

BAFF/BLyS Gene Expression Predicts Disease Activity in Systemic Lupus Erythematosis Over One Year
Abstract Number: 2429

Balancing Work and Health: Do Younger Workers Experience More Work-Health Conflict Than Middle- and Older-Aged Workers with Rheumatic Diseases?
Abstract Number: 1577

Barriers to Recruit Unaffected Family Members of Patients with Rheumatoid Arthritis
Abstract Number: 1234

Barriers, Benefits and Preferences for Exercise in RA Patients: A Cross Sectional Study
Abstract Number: 398

Basal Metabolic Rate As an Indicator of Rheumatoid Arthritis Disease Activity and Predictor of Remission
Abstract Number: 1237

Baseline Evaluation of Insulin Resistance in Patients with early Non-Treated Rheumatoid Arthritis
Abstract Number: 2158

Baseline Folate Related Biomarkers in Serum and erythrocytes Are Not Associated with Methotrexate Response and Adverse Events in Rheumatoid Arthritis
Abstract Number: 1107

Baseline Knee Flexion Pain, Age and Joint Line Tenderness Predict the Progression of Asymptomatic, Radiographic Knee Osteoarthritis to Symptomatic Knee Osteoarthritis Over 5 Years
Abstract Number: 615

Baseline Laboratory Characteristics From the Combined Placebo Groups in the Phase 3 Belimumab Trials Are Predictive of Severe Flare At 52 Weeks
Abstract Number: 1573

Baseline Screening Recommendations for Rheumatoid Arthritis Patients Treated with Disease Modifying Anti-Rheumatic Drugs: Does an Educational Intervention Change Practice in an Outpatient Clinic?
Abstract Number: 431

Basic and Clinical Significance of Interleukin 6 (IL-6) in AA Amyloidosis with RA
Abstract Number: 601

Bath Ankylosing Spondylitis Functional Index (BASFI) Is a Better Indicator of Poor Quality of Life Than Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in Ankylosing Spondylitis: Results From SIRAS – the Scotland and Ireland Registry for Ankylosing Spondylitis
Abstract Number: 2376

Behcet’s Disease: Combination of Pulse Cyclophosphamide, Azathioprine, and Prednisolone for the Treatment of Retinal Vasculitis; Longitudinal Study On 10 Years
Abstract Number: 1341

Beneficial Effect of Anti-TNF Therapy in the Lipoprotein Atherogenic Risk Profile in Comparison with DMARD Standard Therapy in RA Patients
Abstract Number: 757

Beneficial Role of Rapamycin in Experimental Autoimmune Myositis
Abstract Number: 2652

Benefits of Aerobic Training in Patients with Ankylosing Spondylitis Are Not Coupled by Effects On Cytokines: A Randomized Controlled Trial
Abstract Number: 2695

Benefits of the Chronic Disease Self-Management Program in Low-Income African American Women with Systemic Lupus Erythematosus: Results of a Pilot Test
Abstract Number: 84

Benefits of Treat-to-Target Guideline Compliance in Patients with Rheumatoid Arthritis: A Retrospective Claims Analysis
Abstract Number: 1562

Benign Joint Hypermobility Syndrome More Common Than Expected,Both in Controls and in SLE Patients
Abstract Number: 458

Better Retention RATE At 5 YEARS of ANTI-TNF Agents USED in Conjonction with Methotrexate Over Time in Patients with Rheumatoid Arthritis: REAL-Life DATA From Rhumadata Computarized Database
Abstract Number: 616

Bioavailability, Pharmacokinetics, and Safety of Belimumab Administered Subcutaneously in Healthy Subjects
Abstract Number: 457

Biologic Disease-Modifying Anti-Rheumatic Drugs and the Risk of Non-Vertebral Osteoporotic Fractures in Patients with Rheumatoid Arthritis Aged 50 Years and Over
Abstract Number: 2638

Biologic Switching Among Patients with Rheumatoid Arthritis in the United States, 2004-2011
Abstract Number: 1801

Biological Roles of C5orf30 in Rheumatoid Arthritis
Abstract Number: 1642

Biologics and Mortality Risk in Rheumatoid Arthritis – Results of a Population Based Study
Abstract Number: 1923

Biologics in Relapsing Polychondritis: A Single Center Case-Series
Abstract Number: 1709

Biomarkers of Atherosclerosis Are Associated with Progression of Non-Cardiovascular Damage in Patients with SLE
Abstract Number: 2498

Biomarkers of Mitochondrial Dysfunction Correlate with Disease Activity in SLE
Abstract Number: 719

Biomarkers of Pulmonary Hypertension in Patients with Scleroderma: A Case-Control Study
Abstract Number: 790

Biomechanical Function Agrees with Clinical Implications of Foot Disorders in a Population-Based Study
Abstract Number: 1512

Bleomycin Delivery by Osmotic Pump: A Superior Model for Human ILD
Abstract Number: L6

Blisibimod, an Inhibitor of B Cell Activating Factor, in Patients with Moderate-to-Severe Systemic Lupus Erythematosus
Abstract Number: 332

Blockade of CTGF Restores Aberrant Ostoclastgenesis in Collagen Induced Arthritis (CIA) Mice Through Inhibition of Th-17 Differentiation
Abstract Number: 2681

Blocking the Serum Protease Inhibitor Activity of Plasminogen Activator Inhibitor-1 Protects Mice From Development of Glomerulonephritis in a Model of Lupus Nephritis
Abstract Number: 2392

Blood Vessel Instability and Oxidative Damage in Giant Cell Arteritis
Abstract Number: 312

Blood-Based Biomarkers of Neurocognitive Dysfunction in Childhood-Onset Systemic Lupus Erythematosus
Abstract Number: 800

BMI, Occupational Activity, and Leisure-Time Physical Activity: an Exploration of Risk Factors and Modifiers for Knee Osteoarthritis
Abstract Number: 2395

Body Composition, Strength, and Function in Elderly Patients with Giant Cell Arteritis
Abstract Number: 478

Body Mass Index Negatively Influences the Response to Infliximab in Rheumatoid Arthritis
Abstract Number: 2582

Bone Anabolic Changes Progress in Psa Patients Despite Treatment with Methotrexate or Tumour Necrosis Factor Inhibitors
Abstract Number: 2072

Bone Formation and Resorption Are Both Increased in Autoimmune Arthritis
Abstract Number: 1010

Bone Loss Before Clinical Onset of Rheumatoid Arthritis o Subjects with Anti-Citrullinated Protein Antibodies
Abstract Number: 271

Bone Marrow Lesions in Knees with Osteoarthritis: Can Parameters From Dynamic Contrast Enhancement Predict Change in Bone Marrow Lesion Volume or Knee Pain Change?
Abstract Number: 38

Bone Marrow Lesions On Magnetic Resonance Imaging Are Not Associated with Regions of Hypermetabolism in an Animal Model of Osteoarthritis
Abstract Number: 1958

Bone Mineral Density in Lupus Erythematosus Women One Year After Rituximab Therapy
Abstract Number: 2583

Bone Structure and Perfusion Quantification of Bone Marrow Edema and Pannus Tissue Areas in the Wrist of Patients with RA
Abstract Number: 125

Borderline Right Ventricular Involvement in Patients with Systemic Sclerosis without Pulmonary Hypertension
Abstract Number: 295

Brain Biopsy Diagnosis in Magnetic Resonance Imaging Negative Childhood Primary Angiitis of the Central Nervous System
Abstract Number: 587

Brain MRI and Psychophysics Analysis Demonstrate Neuropathic Pain to Be a Component of Back Pain in Ankylosing Spondylitis
Abstract Number: 2525

Bruton’s Tyrosine Kinase Inhibition Suppresses Inflammatory Cytokine Production and Affects Gene Expression in Human Macrophages and RA Synovial Tissue Explants
Abstract Number: 2526

Bruton′s Tyrosine Kinase and Calreticulin: A Novel Interaction with Implications for Inflammatory and Autoimmune Disease
Abstract Number: 1856

Burden of Adverse Events Associated with Immunosuppressant Therapy for the Treatment of Systemic Lupus Erythematosus: A Systematic Literature Review
Abstract Number: 304

Burden of Childhood Central Nervous System Vasculitis: Identifying High Risk Factors for Poor Cognitive Outcome
Abstract Number: 1017

Bye Bye Biopsy: Diffusion Tensor and Dynamic Contrast Enhance Magnetic Resonance Imaging Parameters Reflect Molecular Events of Inflammation in the Synovium

Jump to: View All • a [b] c d e f g h i j k l m n o p q r s t u v w x y z